register

Medical

The Gut-Brain connection

Health Industry Hub | September 4, 2019 |

For centuries, treating neurological conditions meant developing therapies or drugs that directly targeted the brain. Today the evidence argues that research, drugs, and therapy should actually focus on the gut.

The gut and brain have a unique connection that allows for communication past the brain’s main line of defense – the blood brain barrier. Many molecules that cross over the blood brain barrier are created by the gut microbiome, meaning that the brain and gut directly influence one another.

Watch the fascinating video to learn how the gut-brain pathway may lead us to discover causes behind, and even treatments for, life-altering conditions like Autism Spectrum Disorder and Parkinson’s Disease. By understanding communication between the gut and the brain, we may be able to change the course of neurological disease for generations.

About Sarkis Mazmanian

Medical microbiologist Sarkis K. Mazmanian is leading research into how the gut microbiome impacts and communicates with the immune and nervous systems. His work is specifically focused on how this two-way internal communication highway, known as the “gut-brain axis,” influences complex diseases of the brain, such as Parkinson’s and Alzheimer’s diseases. Sarkis has received numerous awards including the MacArthur Foundation “Genius” award and Discover Magazine’s “Best Brains in Science.” Currently the Luis & Nelly Soux Professor of Microbiology in the Division of Biology and Biological Engineering at the California Institute of Technology, Sarkis is also a founder of two biotech companies and the proud mentor of countless students and postdoctoral fellows who have gone on to successful independent careers in medicine, industry, and academia.

You may also like Australian researchers reveal new insights into retina’s genetic code


News & Trends - MedTech & Diagnostics

$54 million cancer centre opens in one of Australia’s fastest growing communities

Health Industry Hub | March 28, 2024 |

MedTech & Diagnostics News: Cancer care provider, GenesisCare, is now treating patients at a new $54 million integrated cancer centre […]

More


Marketing & Strategy

Bayer, MSD and Takeda among winners at Asia Pacific awards

Bayer, MSD and Takeda among winners at Asia Pacific awards

Health Industry Hub | March 28, 2024 |

Bayer, MSD, Takeda, Alcon, and Cipla emerge as winners among this week’s announcements of Asia Pacific awards which celebrate organisations […]

More


News & Trends - MedTech & Diagnostics

Queensland elevates diagnostic precision with cutting-edge imaging technology

Queensland elevates diagnostic precision with cutting-edge imaging technology

Health Industry Hub | March 28, 2024 |

MedTech & Diagnostics News: Mackay Base Hospital and Qscan Mackay have unveiled state-of-the-art medical imaging machines to elevate patient care […]

More


News & Trends - Pharmaceuticals

Landmark collaboration sparks inauguration of precision care clinic

Landmark collaboration sparks inauguration of precision care clinic

Health Industry Hub | March 28, 2024 |

Pharma News: In a landmark collaboration, Australians with cancer will receive more personalised care through the newly established Precision Care […]

More


This content is copyright protected. Please subscribe to gain access.